Second, a recent study has suggested that dabigatran prevents cancer spread in mice with colon cancer by obliterating transforming growth factor-β1 (TGF-β1), an immunosuppressive cytokine with important roles in oncogenesis; therefore, we could not rule out competing effects on cancer progression [37]. Here, TGFB1 is linked to colonic neoplasm.